JCI-accredited hospitals · 45+ hospitals & clinics · Patients from 90+ countries · 24/7 multilingual coordination
Article

The Understanding Moyamoya Disease Causes and Risks Understanding Moyamoya Disease Causes and Risks

3 min read
Published by Acibadem Health Point Last updated June 5, 2025

Understanding Moyamoya Disease Causes and Risks Understanding Moyamoya Disease Causes and Risks

Understanding Moyamoya Disease Causes and Risks Understanding Moyamoya Disease Causes and Risks

Moyamoya disease is a rare, progressive cerebrovascular disorder characterized by the narrowing or blockage of arteries at the base of the brain, particularly the internal carotid arteries and their main branches. As these large arteries gradually constrict, smaller, fragile blood vessels develop to compensate for reduced blood flow. These collateral vessels resemble a “puff of smoke” on imaging studies, which is what the Japanese term “moyamoya” signifies. Despite its distinctive appearance, the exact cause of Moyamoya remains elusive, though ongoing research has shed light on several contributing factors and risk elements. Understanding Moyamoya Disease Causes and Risks Understanding Moyamoya Disease Causes and Risks

Genetics play a significant role in Moyamoya disease, especially in cases where the condition is familial. In such instances, individuals inherit genetic mutations that predispose them to abnormal arterial development and constriction. Certain gene variants, particularly found in East Asian populations, have been linked to increased susceptibility. For example, mutations in the RNF213 gene are strongly associated with Moyamoya disease, suggesting a genetic component that influences blood vessel integrity and growth. However, not everyone with these genetic markers develops the disease, indicating that other factors are also at play. Understanding Moyamoya Disease Causes and Risks Understanding Moyamoya Disease Causes and Risks

Environmental factors and medical conditions can influence the risk of developing Moyamoya. While the precise environmental triggers are not well understood, some studies suggest that infections, autoimmune responses, or other inflammatory processes may contribute to arterial

damage or abnormal vessel formation. Additionally, Moyamoya is often associated with other medical conditions such as sickle cell anemia, neurofibromatosis type 1, Down syndrome, and certain thyroid disorders. These underlying conditions may alter blood vessel health or provoke inflammatory responses, increasing vulnerability to arterial narrowing.

Age is another important factor in Moyamoya disease. It has a bimodal distribution, often affecting children between 5 and 10 years old and adults between 30 and 40 years old. The reasons behind this age pattern are not fully understood, but it suggests different pathogenic mechanisms or triggers at different life stages. Children with Moyamoya frequently present with strokes or transient ischemic attacks, while adults may experience headaches, seizures, or ischemic strokes. Understanding Moyamoya Disease Causes and Risks Understanding Moyamoya Disease Causes and Risks

Understanding Moyamoya Disease Causes and Risks Understanding Moyamoya Disease Causes and Risks Risk factors extend beyond genetics and associated conditions. The presence of hypertension, smoking, and high cholesterol levels can exacerbate arterial damage and increase the likelihood of cerebrovascular events in individuals already predisposed to Moyamoya. These modifiable risk factors highlight the importance of managing overall cardiovascular health to potentially reduce disease progression and prevent strokes.

Understanding Moyamoya Disease Causes and Risks Understanding Moyamoya Disease Causes and Risks Understanding the causes and risks associated with Moyamoya disease is crucial for early diagnosis and effective management. While genetic predisposition is significant, environmental influences and associated medical conditions also contribute to its development. Recognizing symptoms early and assessing individual risk factors can lead to timely interventions, which are essential to prevent serious complications such as strokes and neurological deficits. Continued research is necessary to fully unravel the complex mechanisms behind Moyamoya, offering hope for more targeted therapies and improved outcomes in the future.

We’re With You at Every Step

How can we help you today?

Treatments are delivered at our JCI-accredited hospitals — Acıbadem International
We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.